DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

133.06 1.09 (0.83%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRTX $133.06 0.83%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $132.63
Previous Close $131.97
Daily Range $132.63 - $134.23
52-Week Range $97.45 - $143.45
Market Cap $32.7B
P/E Ratio -48.16
Dividend (Yield) $0.00 (0.0%)
Volume 340,914
Average Daily Volume 1,752,801
Current FY EPS -$2.28




Drug Makers

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website:

News & Commentary Rss Feed

3 Biotech Stocks to Buy in December

Are you interested in putting a few biotech stocks on your holiday wish list? Our contributors think you should give these three names a look.

The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, Gilead, Biogen and Repros

Biotech Stock Roundup: KaloBios Soars as Shkreli Steps In, FDA Panel Not Convinced about BioMarin Dr

Biotech Stock Roundup: KaloBios Soars as Shkreli Steps In, FDA Panel Not Convinced about BioMarin Drug

Vertex's (VRTX) Orkambi Approved in EU for Cystic Fibrosis

Instant Analysis: Vertex Pharmaceuticals Grabs an Important Regulatory Win

This one is a big deal.

Instant Analysis: Vertex Pharmaceuticals Scores 2 Regulatory Wins

But will it move the needle?

Biotech Stock Roundup: Clovis Plunges, Label Expansion for Gilead's Harvoni

Vertex Pharmaceuticals Incorporated Moved 16% Higher in October -- Here's Why

A great-looking third-quarter report sends shares of the cystic fibrosis leader higher.

Vertex Receives Two EU Approvals for KALYDECO for Cystic Fibrosis

5 Drugs That Are the Face of Prescription Drug Reform

Congress is cracking down on rising prescription drug costs, and these five therapies could prove to be the face of that reform.

See More VRTX News...

VRTX's Top Competitors

VRTX $133.06 (0.83%)
Current stock: VRTX
AMGN $163.52 (-0.26%)
Current stock: AMGN
GILD $108.00 (0.20%)
Current stock: GILD
BIIB $293.21 (0.31%)
Current stock: BIIB